Clinical trials in triple negative breast cancer-Reference-Cited by-同舟云学术

Clinical trials in triple negative breast cancer

Published:2011-03-15 Issue:1-2 Volume:32 Page:123-136
ISSN:1558-1551
Container-title:Breast Disease
language:
Short-container-title:BD

Author:

Reeder-Hayes Katherine E.¹,Carey Lisa A.²,Sikov William M.³

Affiliation:

1. Department of Hematology-Oncology, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA

2. Department of Medicine, University of North Carolina at Chapel Hill, Associate Director, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA

3. Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA

Publisher

IOS Press

Subject

Cancer Research,Oncology,General Medicine

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancement of cell-penetrating peptides in combating triple-negative breast cancer;Drug Discovery Today;2022-11

2. Complement-Mediated Selective Tumor Cell Lysis Enabled by Bi-Functional RNA Aptamers;Genes;2021-12-29

3. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells;Life Sciences;2021-02

4. Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer;npj Systems Biology and Applications;2019-07-08

Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression

;Cancer Management and Research;2019-06